Friday, February 7, 2025
spot_imgspot_img

Top 5 This Week

spot_imgspot_img

Related Posts

Haoxi Health Technology Limited Completes $12 Million Underwritten Follow-on Public Offering – GlobeNewswire


Haoxi Health Technology Limited has successfully closed a $12 million underwritten follow-on public offering. The company announced the news today through a press release on GlobeNewswire.

The offering consisted of the sale of ordinary shares by Haoxi Health Technology Limited, with additional shares offered by certain selling shareholders. The underwriters also have been granted a 30-day option to purchase up to an additional 15% of the shares offered in the public offering.

Haoxi Health Technology Limited is a leading health technology company that focuses on providing innovative solutions for healthcare providers and patients. The funds raised from this public offering will be used to further develop and expand its product offerings, enhance its technology infrastructure, and strengthen its market presence.

“We are thrilled to have closed this follow-on public offering successfully,” said a spokesperson from Haoxi Health Technology Limited. “The support and confidence of our investors are a testament to the strength of our business model and the potential for growth in the health technology sector. We look forward to using these funds to drive innovation and continue to provide valuable solutions to our customers.”

The underwritten public offering was managed by leading investment banks, who acted as joint book-running managers for the offering. The offering was made only by means of a prospectus, which can be obtained from the SEC website.

With the successful closing of this public offering, Haoxi Health Technology Limited is poised for continued growth and success in the health technology industry. Investors and industry professionals are encouraged to keep an eye on this innovative company as it continues to make strides in improving healthcare technology.

Source
Photo credit news.google.com

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Popular Articles